Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 5/20 | 0.64 |
| ▸ | ANPEP | P15144 | 5/20 | 0.64 |
| ▸ | ACP3 | P15309 | 5/20 | 0.62 |
| ▸ | SRC | P12931 | 1/20 | 0.52 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.50 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | XIAP | P98170 | 1/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2224720 | 0.86 | LAP3 (0.55) | LAP3ANPEPACP3SRCCYP1A2 | |
| SCHEMBL7158870 | 0.82 | LAP3 (0.64) | LAP3ANPEPACP3ERAP1ERAP2 | |
| SCHEMBL27481841 | 0.80 | LAP3 (0.62) | LAP3ANPEPACP3ERAP1ERAP2 | |
| SCHEMBL10714585 | 0.80 | LAP3 (0.62) | LAP3ANPEPACP3ERAP1ERAP2 | |
| SCHEMBL16057402 | 0.79 | LAP3 (0.47) | LAP3ANPEPACP3ERAP2CYP1A2 | |
| SCHEMBL2375608 | 0.78 | LAP3 (1.00) | LAP3ANPEPACP3ERAP1ERAP2 | |
| SCHEMBL8740148 | 0.78 | LAP3 (1.00) | LAP3ANPEPACP3ERAP1ERAP2 | |
| SCHEMBL8341042 | 0.78 | LAP3 (0.60) | LAP3ANPEPACP3ERAP1ERAP2 | |
| SCHEMBL10710542 | 0.78 | LAP3 (0.60) | LAP3ANPEPACP3ERAP1ERAP2 | |
| SCHEMBL31343657 | 0.78 | LAP3 (0.60) | LAP3ANPEPACP3ERAP1ERAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0759976-A4 | THE ISOLATION AND PRODUCTION OF CATALYTIC ANTIBODIES USING PHAGE TECHNOLOGY | IGEN INT INC (US) | 2001-02-07 | — | — | EP | disclosed |
| US-5855885-A | FROM BACTERIOPHAGE; CLONING, SCREENING | WELLSTAT BIOCATALYSIS, LLC | 1999-01-05 | — | — | US | disclosed |
| EP-0759976-A1 | THE ISOLATION AND PRODUCTION OF CATALYTIC ANTIBODIES USING PHAGE TECHNOLOGY | IGEN, INC. (US) | 1997-03-05 | — | — | EP | disclosed |
| WO-1996000733-A1 | DIPHOSPHATE OR TRIPHOSPHATE NON-HYDROLYSABLE STABLE ANALOGUES AND METHODS FOR THEIR PREPARATION | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1996-01-11 | — | — | WO | disclosed |
| WO-1995027045-A1 | THE ISOLATION AND PRODUCTION OF CATALYTIC ANTIBODIES USING PHAGE TECHNOLOGY | IGEN, INC. (US) | 1995-10-12 | — | — | WO | disclosed |